In the aesthetic clinical practice, botulinum toxin type A (BoNT-A) is best known for its use as a neuromodulator for the treatment of dynamic facial lines; however, when injected intradermally as microdroplets, BoNT-A can improve skin quality and overall skin appearance.

Objectives
To discuss key aspects of microtoxin use in clinical practice and provide expert guidance on use.

As part of a Continuing Medical Education (CME) lecture series and roundtable, the authors discussed key aspects of microtoxin patient selection, injection technique, and safety.